Twice‐a‐day radiotherapy for T3 squamous cell carcinoma of the glottic larynx
- 1 March 1989
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 11 (2) , 123-128
- https://doi.org/10.1002/hed.2880110204
Abstract
Between March 1978 and April 1986, 21 previously untreated patients with T3 squamous cell carcinoma of the true vocal cord received radical courses of twice-a-day radiotherapy (120 cGy twice daily) to total doses of 7,440–7,680 cGy. The rate of local control at the primary site was 67% after radiotherapy. The ultimate control rate after salvage surgery was 83%. Five-year absolute and cause-specific survival rates were 59% and 81%, respectively. It is concluded that radiotherapy is a rational approach for many patients with T3 glottic cancer.Keywords
This publication has 6 references indexed in Scilit:
- Prognostic value of vocal cord fixation with respect to treatment in cancers of the supraglottis and pyriform sinusThe Laryngoscope, 1987
- Stage T3 squamous cell carcinoma of the glottic larynx treated with surgery and/or radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1984
- T3 glottic cancer: An analysis of dose time-volume factorsInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Early glottic carcinoma: Factors affecting radiation failure, results of treatment and sequelaeInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Panel discussion on glottic tumors. VII. The management of glottic carcinoma by primary irradiation with surgery in reserveThe Laryngoscope, 1975
- Maximum utilization of the life table method in analyzing survivalJournal of Chronic Diseases, 1958